StonvexLoading…
StonvexStonvexStonvexCore line items from BAH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | $11.98B | $10.66B | $9.26B | $8.36B |
Operating Income | $1.37B | $1.01B | $447.00M | $685.18M |
Net Income | $935.00M | $606.00M | $272.00M | $466.74M |
EPS (Diluted) | $7.25 | $4.59 | $2.03 | $3.44 |
Total Assets | $7.31B | $6.56B | $6.55B | $6.03B |
Total Liabilities | $6.31B | $5.52B | $5.56B | $4.98B |
Cash & Equivalents | $885.00M | $554.00M | $404.86M | $695.91M |
Free Cash Flow OCF − CapEx | $911.00M | $192.00M | $527.00M | $656.56M |
Shares Outstanding | 124.88M | 129.64M | 131.64M | 132.58M |